eplex bcid panels Search Results


90
GenMark Diagnostics dx eplex blood culture identification gramnegative panel
Dx Eplex Blood Culture Identification Gramnegative Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dx eplex blood culture identification gramnegative panel/product/GenMark Diagnostics
Average 90 stars, based on 1 article reviews
dx eplex blood culture identification gramnegative panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex bcid-fp panel
Summary of CDC algorithm ([ <xref ref-type= 32 ], modified)." width="250" height="auto" />
Eplex Bcid Fp Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eplex bcid-fp panel/product/GenMark Diagnostics
Average 90 stars, based on 1 article reviews
eplex bcid-fp panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioFire Defense eplex bcid fungal pathogen panels
Summary of CDC algorithm ([ <xref ref-type= 32 ], modified)." width="250" height="auto" />
Eplex Bcid Fungal Pathogen Panels, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eplex bcid fungal pathogen panels/product/BioFire Defense
Average 90 stars, based on 1 article reviews
eplex bcid fungal pathogen panels - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics rapid molecular diagnostic tests genmark eplex bcid-gn panel
Distribution of Gram-negative bacteria identified by MALDI-ToF and <t> ePlex </t> from March 2019 to February 2021
Rapid Molecular Diagnostic Tests Genmark Eplex Bcid Gn Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapid molecular diagnostic tests genmark eplex bcid-gn panel/product/GenMark Diagnostics
Average 90 stars, based on 1 article reviews
rapid molecular diagnostic tests genmark eplex bcid-gn panel - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioFire Defense eplex bcid ruo panels
Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of <t>ePlex</t> <t>BCID</t> panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID <t>RUO</t> or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).
Eplex Bcid Ruo Panels, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/eplex bcid ruo panels/product/BioFire Defense
Average 90 stars, based on 1 article reviews
eplex bcid ruo panels - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Summary of CDC algorithm ([ <xref ref-type= 32 ], modified)." width="100%" height="100%">

Journal: Journal of Fungi

Article Title: An Overview on Candida auris in Healthcare Settings

doi: 10.3390/jof9090913

Figure Lengend Snippet: Summary of CDC algorithm ([ 32 ], modified).

Article Snippet: GenMark ePlex BCID-FP Panel , , Yes , n/a.

Techniques: Modification, Software

Distribution of Gram-negative bacteria identified by MALDI-ToF and  ePlex  from March 2019 to February 2021

Journal: Microbiology Spectrum

Article Title: Correlation between Identification of β-Lactamase Resistance Genes and Antimicrobial Susceptibility Profiles in Gram-Negative Bacteria: a Laboratory Data Analysis

doi: 10.1128/spectrum.01485-21

Figure Lengend Snippet: Distribution of Gram-negative bacteria identified by MALDI-ToF and ePlex from March 2019 to February 2021

Article Snippet: The use of rapid molecular diagnostic (RMD) tests such as GenMark ePlex BCID-GN panel allows surveillance of CTX-M ESBL and common carbapenemases at a molecular level in Gram-negative bacteria.

Techniques: Bacteria

Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Clinical isolates by final susceptibility phenotype profile among Gram-negative and Gram-positive organisms by treatment based on results of ePlex BCID panels versus Verigene BC. Comparison of theoretical antibiotic management decisions based on GenMark ePlex BCID RUO or Vergine BC results by final organism susceptibility profile. NA, no routine susceptibility testing (e.g., coagulase-negative Staphylococcus ) or uncommon profile (e.g., Stenotrophomonas maltophilia ).

Article Snippet: Recently, the ePlex BCID RUO panels were compared to the BioFire FilmArray blood culture ID (BCID) panel in 137 clinical blood cultures ( ).

Techniques: Comparison

Comparison of RDT platforms

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT)

doi: 10.1128/AAC.00441-21

Figure Lengend Snippet: Comparison of RDT platforms

Article Snippet: Recently, the ePlex BCID RUO panels were compared to the BioFire FilmArray blood culture ID (BCID) panel in 137 clinical blood cultures ( ).

Techniques: Comparison, Bacteria